Patents Assigned to NANJING YSY BIOTECH COMPANY LTD.
  • Patent number: 11795509
    Abstract: A screening kit for paroxysmal supraventricular tachycardia contains a reagent for detecting a human CACNA1B gene c. 1700A>G mutation site at base No. 1700 in a coding region of CACNA1B gene from A to G.
    Type: Grant
    Filed: September 10, 2020
    Date of Patent: October 24, 2023
    Assignees: SICHUAN PROVINCIAL PEOPLE'S HOSPITAL, CHENGDU MEDICAL COLLEGE, NANJING YSY BIOTECH COMPANY LTD.
    Inventors: Xiaoping Li, Rong Luo, Qingshun Zhao, Zhenglin Yang, Tao He, Mingjiang Liu